Long-term efficacy of indicated prevention of depression in non-professional caregivers: randomized controlled trial.
P Otero, F Smit, P Cuijpers...
https://pubmed.ncbi.nlm.nih.gov/25331992Actively Recruiting
Led by University of Santiago de Compostela · Updated on 2026-05-05
212
Participants Needed
1
Research Sites
N/A
Total Duration
U
University of Santiago de Compostela
Lead Sponsor
M
Ministry of Science and Innovation, Spain
Collaborating Sponsor
Suicide is a significant public health issue, especially affecting adults aged 50 and older. This research aims to evaluate the effectiveness of a brief problem-solving psychological intervention designed to prevent suicide in this age group. The study addresses the need for accessible interventions that can be delivered face-to-face, by telephone conference call, or through a smartphone app, expanding options beyond traditional face-to-face therapy. Participants will be randomly assigned to one of four groups: a face-to-face group receiving six weekly 90-minute problem-solving sessions, a telephone conference call group with the same format and duration, a smartphone app group completing six modules of similar content and length, or a usual care group receiving standard psychotherapy or medication as determined by their health providers. The intervention includes training in problem-solving, mood monitoring, relaxation, mindfulness, and coping strategies. Before the intervention, information on demographics, family and personal history, and suicide risk will be collected. Participants will be assessed at post-intervention (7 weeks) and at 3, 6, and 12 months to measure changes in suicidal thoughts, hopelessness, anxiety, depression, reasons for living, impulsivity, problem-solving skills, social support, anger, treatment adherence, and satisfaction. The study will monitor outcomes and safety over this period to evaluate the intervention's impact.
CONDITIONS
Brief Problem-solving Intervention in Different Formats for the Prevention of Suicide in Adults Over 50
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 6 weeks
Participants receive a problem-solving psychological intervention delivered either face-to-face, via telephone conference call, or through a smartphone app. The intervention consists of 6 weekly sessions, each approximately 90 minutes long, focused on behavioral and cognitive skills for suicide prevention.
Weekly visits or interactions for 6 sessions depending on format
Duration - Up to 12 months
Participants are followed to assess changes in suicidal ideation and other psychological outcomes at 3, 6, and 12 months after treatment completion.
Approximately 3 follow-up assessments
Total: 1 location
1
Research Group on Mental Health and Psychopatology
Santiago de Compostela, A Coruña, Spain, 15782
Actively Recruiting
F
Fernando L. Vázquez González, PhD.
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
P Otero, F Smit, P Cuijpers...
https://pubmed.ncbi.nlm.nih.gov/25331992Fernando L Vázquez González, Patricia Otero Otero, Angela Torres Iglesias...
https://pubmed.ncbi.nlm.nih.gov/23336549Lara López, Filip Smit, Pim Cuijpers...
https://pubmed.ncbi.nlm.nih.gov/31017076Alessandra Xavier, Patricia Otero, Vanessa Blanco...
https://pubmed.ncbi.nlm.nih.gov/31237377A T Beck, M Kovacs, A Weissman
https://pubmed.ncbi.nlm.nih.gov/469082Kelly Posner, Gregory K Brown, Barbara Stanley...
https://pubmed.ncbi.nlm.nih.gov/22193671A T Beck, A Weissman, D Lester...
https://pubmed.ncbi.nlm.nih.gov/4436473M M Linehan, J L Goodstein, S L Nielsen...
https://pubmed.ncbi.nlm.nih.gov/6841772J H Patton, M S Stanford, E S Barratt
https://pubmed.ncbi.nlm.nih.gov/8778124W E Broadhead, S H Gehlbach, F V de Gruy...
https://pubmed.ncbi.nlm.nih.gov/3393031